11 results on '"Haslbauer F"'
Search Results
2. 195P REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
3. 172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC)
4. Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis
5. Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer
6. Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
7. Sompas: a Prospective, Non-Interventional Study (Nis) of the Management of Symptomatic Chemotherapy (Ct)-Induced Anemia (Cia) in Patients (Pts) with Colorectal (Crc), Breast (Bc) or Lung Cancer (Lc) in Austria (At) and Switzerland (Ch)
8. Anemia Point Prevalence in Patients Receiving Chemotherapy in 56 Centers in Italy and Austria
9. 0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapy
10. Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
11. Continued trastuzumab therapy for patients with HER2-positive breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.